ORMP

Oramed Pharmaceuticals Inc. News Headlines

$8.17
*  
0.24
2.85%
Get ORMP Alerts
*Delayed - data as of Apr. 17, 2015  -  Find a broker to begin trading ORMP now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By











The Importance Of Being Oral
6/3/2014 6:32:00 PM - Seeking Alpha


Does Oramed Pharmaceuticals Pass The Smell Test?
5/23/2014 12:06:00 PM - Seeking Alpha






Sector Update: Healthcare
2/10/2014 2:38:47 PM - MT Newswires


The Dream Of The Insulin Pill: Oramed Vs. Rivals
2/6/2014 6:51:00 AM - Seeking Alpha




Oramed's Data Will Define A New Standard For Diabetes
1/28/2014 7:48:00 AM - Seeking Alpha




Sector Update: Healthcare
1/27/2014 4:58:30 PM - MT Newswires


3 Small Biotech Companies Poised For Big Growth In 2014
1/21/2014 1:07:00 PM - Seeking Alpha




Sector Update: Healthcare
12/26/2013 2:41:43 PM - MT Newswires




Sector Update: Healthcare
12/26/2013 9:07:19 AM - MT Newswires




Sector Update: Healthcare
10/3/2013 2:32:18 PM - MT Newswires




Oramed Expands Diabetes Platform With Oral GLP-1 Agonist
8/5/2013 4:29:00 PM - Seeking Alpha


Oramed: An Early-Stage Biotech Company With Huge Potential
7/17/2013 12:40:00 PM - Seeking Alpha